Though the clinical presentation and age of onset are impacted by additional genetic modifiers such as TMEM106B [14–17], the disease penetrance approximates 100%, making GRN mutations causal for FTD [18–20]. The gene discussed is GRN; the disease is frontotemporal dementia.